In a remarkable case, a 63-year-old Norwegian man, referred to as the “Oslo patient,” appears to have been cured of his lifelong HIV infection. This unexpected outcome occurred following a stem cell transplant performed to treat a life-threatening blood cancer. The donor, the patient’s brother, possessed a rare CCR5-delta 32 mutation that confers natural resistance to HIV. Four years post-transplant and two years after discontinuing antiretroviral therapy, the patient remains free of the virus, offering significant insight into potential HIV cure strategies.
Read More
Researchers at the Peter Doherty Institute have developed a novel mRNA delivery method using lipid nanoparticles (LNP X) to successfully reveal hidden HIV in human white blood cells, a major hurdle in developing an HIV cure. This method, detailed in *Nature Communications*, utilizes mRNA encased in these specially designed nanoparticles, instructing infected cells to expose the virus. While further research, including animal and human trials, is needed to determine efficacy, this breakthrough offers significant potential for eliminating the virus and could have broader implications for treating other diseases. The success rate observed in laboratory settings surpasses previous attempts, raising considerable hope for a functional HIV cure.
Read More
The confirmation of a fifth person cured of HIV is undeniably fantastic news. It represents a significant leap forward in medical science and offers a glimmer of hope for millions living with this virus. However, the reality is that this cure, achieved through a complex and risky stem cell transplant, remains far out of reach for the vast majority of those affected.
This breakthrough, while celebrated, highlights the significant hurdles still present. The procedure itself, typically used for cancer patients with no other options, carries a substantial risk of mortality. Even a 5% chance of death might be a gamble some individuals would take, considering the alternative, but it underscores the urgent need for a less dangerous, more accessible treatment.… Continue reading
John Q. Hosedrinker 
Matt Underwood